RISK FACTORS AND RISK LEVELS FOR TYPE 2 DIABETES MELLITUS USING FINDRISC IN ADULTS
Keywords:
Diabetes Mellitus, Type 2; Risk Factors; AdultAbstract
DOI: https://doi.org/10.46296/gt.v9i17.0369
Abstract
Objective: To determine the risk of developing type 2 diabetes mellitus using the FINDRISC scale in adults without a previous diagnosis of the disease. Methodology: A quantitative, cross-sectional, analytical study was conducted using non-probabilistic convenience sampling. The population consisted of 266 adults aged 20 to 65 years who received care between September 2025 and January 2026. A data collection form and the Finnish Diabetes Risk Score —FINDRISC— scale were applied, considering sociodemographic, clinical, anthropometric, and lifestyle-related variables. Statistical analysis was performed using Microsoft Excel and Jamovi version 24.0, applying descriptive statistics and Spearman’s correlation. Results: The sample showed a balanced sex distribution, with a slight predominance of females at 50.8%. The mean age was 21.14 ± 1.37 years in men and 20.96 ± 1.64 years in women. Physical inactivity and family history of diabetes were present in 100% of the participants. Overweight or obesity was more frequent in men, whereas increased abdominal circumference predominated in women. According to FINDRISC, moderate risk was the most frequent category, followed by high risk. BMI and glucose levels showed positive and statistically significant correlations with the FINDRISC score, whereas sex showed no significant association. Conclusion: The FINDRISC scale made it possible to identify a moderate risk of type 2 diabetes mellitus in young adults, highlighting the need to strengthen preventive interventions focused on physical activity, weight control, glucose monitoring, and education on healthy lifestyles.
Keywords: Diabetes Mellitus, Type 2; Risk Factors; Adult.
Downloads
References
Acosta-Reyes, J., Rodríguez, D., Acosta, T., Aschner, P., Fraga, C., Vazquez-Fernandez, A., . . . Gabriel, R. (2025). Finnish diabetes risk score (findrisc) for type 2 diabetes screening compared with the oral glucose tolerance test: A systematic review and meta-analysis of diagnostic test accuracy. Diabetes Research and Clinical Practice, 229(1), 112480. https://doi.org/10.1016/j.diabres.2025.112480
Agbo, A., Itodo, E., & Dankyau, M. (2022). Performance of the FINDRISC tool in screening for diabetes in a primary care setting. PAMJ One Health, 9(13), 1. https://doi.org/10.11604/pamj-oh.2022.9.13.31221
Ahmad, T., Tauqir, A., Tariq, H., Qureshi, A., Jalaluddin, S., Khan, U., . . . Khan, A. (2025). Sex differences in risk of developing Type 2 Diabetes Mellitus (T2DM): A feasibility assessment of FINDRISC scoring and barriers to disease management in a low-income settlement of Rawalpindi, Pakistan. PLOS Glob Public Health, 5(7), e0003087. https://doi.org/1371/journal.pgph.0003087
Alvarez, J., Chamorro, L., & Ruschel, L. (2023). El test de FINDRISK como primera acción en atención primaria en salud para identificar el riesgo de desarrollo de diabetes mellitus tipo 2 en la población general. Rev. virtual Soc. Parag. Med. Int, 10(1), 41-49. https://doi.org/10.18004/rvspmi/2312-3893/2023.10.01.41
Bagyura, Z., Kiss, L., Panykó, I., Domján, B., Soós, P., Szelid, Z., . . . Tabák, A. (2025). Validation of the Finnish Diabetes Risk Score (FINDRISC) in a Central-European Population for the Prediction of Cumulative Incidence of Type 2 Diabetes Over 8-Years-Follow-Up of the Budakalász Health Examination Survey (BHES). Diabetes Metab Res Rev, 41(8), e70105. https://doi.org/10.1002/dmrr.70105
Betancourt, A., Carrillo, A., Olvera, V., Barragán, L., Valencia, V., Pineda, C., & Zetina, A. (2025). Riesgo de desarrollar diabetes mellitus y su asociación con los hábitos alimentarios en estudiantes universitarios. Arch Latinoam Nutr, 75(1), 8-17. https://doi.org/10.37527/2025.75.1.002
Bohorquez , C., Barreto, M., Muvdi, Y., Rodriguez, A., Badillo, M., & Martínez, W. (2020). FACTORES MODIFICABLES Y RIESGO DE DIABETES MELLITUS TIPO 2 EN ADULTOS JÓVENES: UN ESTUDIO TRANSVERSAL. Ciencia y enfermería, 26(14), 1. https://doi.org/10.29393/ce26-7fmcb70007
Chamorro, L., Álvarez, J., & Ruschel, L. (2024). Detección y seguimiento de pacientes según resultados de la prueba de FINDRISK en Atención Primaria. Rev. Nac. (Itauguá), 16(2), 102-117. https://doi.org/10.18004/rdn2024.may.02.102.117
Díaz, M., Ramírez, J., & Robels, P. (2025). Riesgo para desarrollar diabetes mellitus tipo II con base en la escala FINDRISC. Ciencia Latina, 9(1), 3472. https://doi.org/10.37811/cl_rcm.v9i1.16095
Doğru, B., Gün, M., Çavuşoğlu, E., Çelik, F., & Türk, E. (2024). What is the Risk of Type 2 Diabetes in Relatives of Patients Hospitalized in the Internal Medicine Clinic? A Hospital-Based Survey Study. Cyprus Journal of Medical Sciences, 9(1), 36-42. https://doi.org/10.4274/cjms.2021.3543
Echeverria, L., Ojeda, M., Jara, L., Ayala, C., Cuevas, N., Duarte, M., . . . Galeano, R. (2025). Valoración del riesgo de desarrollar Diabetes Mellitus tipo 2 a través del Test de Findrisc en Villa Mano Abierta, Central - Paraguay 2024. Med. clín. soc, 9(1), e574. https://doi.org/10.52379/mcs.v9.574
Espinoza, G., & Quishpi, V. (2023). Riesgo de diabetes mellitus tipo 2 en adultos según estudios con el test de FINDRISC. Rev. cuba. de Reumatol, 25(4), e1204. https://revreumatologia.sld.cu/index.php/reumatologia/article/view/1204
Fornos-Pérez, J., Mera-Gallego, I., Jaraiz-Magariños, I., Huarte-Royo, J., Mera-Gallego, R., & Andrés-Rodríguez, N. (2023). Detección de personas en riesgo de padecer diabetes en la farmacia comunitaria con el test de Findrisc en los años 2014-2021. Farm Comunitarios, 16(1), 5-17. https://doi.org/10.33620/FC.2173-9218
Gabriel, R., Acosta, T., Florez, K., Anillo, L., Navarro, E., Boukichou, N., . . . Tuomilehto, J. (2021). Validation of the Finnish Type 2 Diabetes Risk Score (FINDRISC) with the OGTT in Health Care Practices in Europe. Diabetes Res Clin Pract, 1(1), 178. https://doi.org/10.1016/j.diabres.2021.108976
Hamasalih, K., Marouf, B., & Mahmood, P. (2025). Application of Finnish Diabetes Risk Score (FINDRISC) in Detecting Subjects at Risk for Type 2 Diabetes Mellitus: Results from Community Pharmacies in Sulaimani City, Iraq. Al-Rafidain J Med Sci, 8(1), 161-167. https://doi.org/10.54133/ajms.v8i1.1746
Kozela, M., Dziewierz, A., Koziara, K., Kowalska-Bobko, I., Biondi-Zoccai, G., Zelek, L., . . . Siudak, Z. (2026). Assessment of the type 2 diabetes risk using the Finnish Diabetes Risk Score questionnaire, and its predictors at the population level in Poland. Pol Arch Intern Med, 136(3), 17224. https://doi.org/10.20452/pamw.17224
Magliano, D., Co-chair, E., & Co-chair, B. (2021). IDF Diabetes Atlas 10th edition scientific committee. IDF DIABETES ATLAS (Décima ed.). Brussels: International Diabetes Federation. https://www.ncbi.nlm.nih.gov/books/NBK581934/
Montero, C., Muana, S., Clavijo, C., Charry, J., & Guerrero, F. (2023). Riesgo para desarrollar diabetes tipo 2 mediante aplicación del test FINDRISC y factores asociados en población adulta del cantón Pucará-Azuay. 2023. Reciamuc, 7(2), 779-794. https://doi.org/10.26820/reciamuc/7.(2).abril.2023.779-794
Nnamudi, A., Orhue, N., Ijeh, I., & Nwabueze, A. (2023). Finnish diabetes risk score outperformed triglyceride-glucose index in diabetes risk prediction. J Diabetes Metab Disord, 22(2), 1337-1345. https://doi.org/10.1007/s40200-023-01252-y
Noriega, P., Llanos, C., Campos, M., & Roca, S. (2025). Riesgo de desarrollo de diabetes mellitus tipo 2 en personal de limpieza de una universidad boliviana . RGCS, 3(1), 93-12. https://doi.org/10.36097/rgcs.v3i1.3220
Peralta, H., Costa, G., & Saleme, A. (2024). Evaluación del puntaje FINDRISC para detección de prediabetes y diabetes tipo 2 sin diagnóstico [FINDRISC as screening for detection of prediabetes and unknown type 2 diabetes]. Medicina (B Aires), 84(1), 1-10. https://pubmed.ncbi.nlm.nih.gov/38271927/
Pesaro, A., Bittencourt, M., Franken, M., Carvalho, J., Bernardes, D., Tuomilehto, J., & Santos, R. (2021). The Finnish Diabetes Risk Score (FINDRISC), incident diabetes and low-grade inflammation. Diabetes Res Clin Pract, 171(1), 108558. https://doi.org/10.1016/j.diabres.2020.108558
Ríos, S., Gutiérrez, R., Gutiérrez, R., Livier, I., Robles, M., & Gutiérrez, J. (2023). Riesgo de desarrollar diabetes mellitus tipo 2 según escala Finnish Diabetes Risk Score en atención primaria. Rev Cubana Med Gen Integr, 39(2), 1. http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252023000200011&lng=es
Sun, H., Saeedi, P., Karuranga, S., Kuo, S., Boyko, E., & Magliano, D. (2022). IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice, 183(1), 109119. https://doi.org/10.1016/j.diabres.2021.109119
Varela-Vega, Y., Roy-García, I., Pérez-Rodríguez, M., & Velázquez-López, L. (2023). Certeza diagnóstica del instrumento FINDRISC para identificar resistencia a la insulina en adultos. Rev Med Inst Mex Seguro Soc, 61(1), 33-41. https://pmc.ncbi.nlm.nih.gov/articles/PMC10395935/
Yovera-Aldana, M., Mezones-Holguin, E., Aguero-Zamora, R., Damas-Casani, L., Uriol-Llanos, B., Espinoza-Morales, F., . . . Ticse-Aguire, R. (2024). External validation of Finnish diabetes risk score (FINDRISC) and Latin American FINDRISC for screening of undiagnosed dysglycemia: Analysis in a Peruvian hospital health care workers sample. PLoS ONE, 19(8), e0299674. https://doi.org/10.1371/journal.pone.0299674
Published
How to Cite
Issue
Section
Copyright (c) 2026 GESTAR Arbitrated Scientific Journal in Health Research. ISSN: 2737-6273.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
